床边制造是个性化医疗的下一步:医学进步和法律挑战
Tämer El Saadany1, Claudia Seitz2, Corina Bräm3
1Division of Oncology/Hematology, Cantonal Hospital Graubünden, Chur, Switzerland.
Journal of law and the biosciences
|July 11, 2024
概括
床边制造提供个性化医疗,但在瑞士和欧盟面临法律障碍. 需要进行监管改革,以确保在现场生产药物的患者安全和产品有效性.
科学领域:
- 制药法 制药法 制药法
- 医疗保健条例 医疗保健条例
- 个性化医疗是个性化的医疗.
背景情况:
- 床边制造或现场制药正在医疗保健中重新出现.
- 这种方法有望彻底改变个性化医疗.
- 然而,在当前的监管框架内,它面临着重大的法律不确定性.
研究的目的:
- 分析瑞士和欧盟围绕床头制造的法律不确定性.
- 突出现有法规 (瑞士治疗产品法,欧盟指令) 对现场药物生产的不足.
- 为了强调在技术进步的背景下需要进行监管改革.
主要方法:
- 审查当前的瑞士和欧盟关于治疗产品的法律框架.
- 分析法律挑战,包括质量保证和责任.
- 识别新型制造技术法规中的漏洞.
主要成果:
- 现有的瑞士和欧盟法规没有充分解决床边制造的独特挑战.
- 关键的法律问题包括质量保证,人为错误的责任和患者安全.
- 新技术加剧了更新法律标准的需要.
结论:
- 一个重新校准的法律环境对于安全有效地整合床边制造业至关重要.
- 监管改革必须平衡创新,患者安全和产品有效性.
- 法律体系必须不断发展,以支持以患者为中心的护理和现场药物生产的增长.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
What is Genetic Engineering?
74.0K
Overview
74.0K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


